shutterstock_45634132_0

African measles cases surge by 700%

pharmafile | July 11, 2019 | News story | Medical Communications, Research and Development |  Africa, Médecins Sans Frontières, measles, pharma 

The number of cases of measles infection on the African continent has surged by 700%, according to data from the World Health Organization.

The stark rise follows the worrying trend around the world, with cases of the potentially fatal disease growing in prevalence across Europe and the US, broadly in line with declining rates of vaccination and mounting anti-vaccine sentiment around the world.

The crisis has led to the Republic of Chad to declare a state of emergency.  While the problem is spreading elsewhere in the world, poor access to adequate preventative treatment is being blamed for the rising crisis across the continent.

As reported by Al Jazeera, Dr Ousmane Houssin, who works in the region, commented: “Ninety percent of children have not been vaccinated because they don’t have access to treatment centres, and so most children under five are infected with the measles virus.”

Advertisement

Berengere Guais, Emergency Coordinator with Medecins Sans Frontieres, also remarked:  “We’re very worried because measles, combined with malnutrition, is a dangerous mix, and there aren’t enough international actors helping Chad’s Ministry of Health to tackle this growing outbreak.”

Matt Fellows

Related Content

Pharma sees climate disruption as growing supply-chain risk

Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to …

AI in pharma: From lab development to patient impact

In the decade to 2025, AI use in vaccine development has increased markedly but is …

CEPI backs African-led Bundibugyo Ebola vaccine development

Minapharm Group is to receive up to US$16.5m from the Coalition for Epidemic Preparedness Innovations …

The Gateway to Local Adoption Series

Latest content